541 related articles for article (PubMed ID: 23907387)
1. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
Sintupisut N; Liu PL; Yeang CH
Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
[TBL] [Abstract][Full Text] [Related]
2. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
[TBL] [Abstract][Full Text] [Related]
3. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
Zhang J; Zhang S; Wang Y; Zhang XS
BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
[TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
Kim YW; Koul D; Kim SH; Lucio-Eterovic AK; Freire PR; Yao J; Wang J; Almeida JS; Aldape K; Yung WK
Neuro Oncol; 2013 Jul; 15(7):829-39. PubMed ID: 23502430
[TBL] [Abstract][Full Text] [Related]
5. Deciphering causal and statistical relations of molecular aberrations and gene expressions in NCI-60 cell lines.
Li SD; Tagami T; Ho YF; Yeang CH
BMC Syst Biol; 2011 Nov; 5():186. PubMed ID: 22051105
[TBL] [Abstract][Full Text] [Related]
6. Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
Kundu S; Cheng Y; Shin M; Manyam G; Mallick BK; Baladandayuthapani V
PLoS One; 2018; 13(7):e0195070. PubMed ID: 30059495
[TBL] [Abstract][Full Text] [Related]
7. Putative effectors for prognosis in lung adenocarcinoma are ethnic and gender specific.
Woolston A; Sintupisut N; Lu TP; Lai LC; Tsai MH; Chuang EY; Yeang CH
Oncotarget; 2015 Aug; 6(23):19483-99. PubMed ID: 26160836
[TBL] [Abstract][Full Text] [Related]
8. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
Li M; Long S; Hu J; Wang Z; Geng C; Ou S
Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
Lehrer S; Rheinstein PH; Rosenzweig KE
Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
[TBL] [Abstract][Full Text] [Related]
10. GSVD comparison of patient-matched normal and tumor aCGH profiles reveals global copy-number alterations predicting glioblastoma multiforme survival.
Lee CH; Alpert BO; Sankaranarayanan P; Alter O
PLoS One; 2012; 7(1):e30098. PubMed ID: 22291905
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of micro-RNA, gene expression, and survival of glioblastoma multiforme.
Huang YT; Hsu T; Kelsey KT; Lin CL
Genet Epidemiol; 2015 Feb; 39(2):134-43. PubMed ID: 25537983
[TBL] [Abstract][Full Text] [Related]
12. Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.
Lu J; Cowperthwaite MC; Burnett MG; Shpak M
PLoS One; 2016; 11(4):e0154313. PubMed ID: 27124395
[TBL] [Abstract][Full Text] [Related]
13. Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma.
Zhang JX; Zhang J; Yan W; Wang YY; Han L; Yue X; Liu N; You YP; Jiang T; Pu PY; Kang CS
Neuro Oncol; 2013 Mar; 15(3):279-89. PubMed ID: 23295773
[TBL] [Abstract][Full Text] [Related]
14. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC
Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406
[TBL] [Abstract][Full Text] [Related]
15. Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups.
Hinrichs BH; Newman S; Appin CL; Dunn W; Cooper L; Pauly R; Kowalski J; Rossi MR; Brat DJ
Acta Neuropathol Commun; 2016 Jan; 4():4. PubMed ID: 26757882
[TBL] [Abstract][Full Text] [Related]
16. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.
Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW
J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920
[TBL] [Abstract][Full Text] [Related]
17. Impact of somatic copy number alterations on the glioblastoma miRNome: miR-4484 is a genomically deleted tumour suppressor.
Nawaz Z; Patil V; Thinagararjan S; Rao SA; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
Mol Oncol; 2017 Aug; 11(8):927-944. PubMed ID: 28378523
[TBL] [Abstract][Full Text] [Related]
18. An integrated analysis of germline and somatic, genetic and epigenetic alterations at 9p21.3 in glioblastoma.
Feng J; Kim ST; Liu W; Kim JW; Zhang Z; Zhu Y; Berens M; Sun J; Xu J
Cancer; 2012 Jan; 118(1):232-40. PubMed ID: 21713760
[TBL] [Abstract][Full Text] [Related]
19. Whole-Genome Multi-omic Study of Survival in Patients with Glioblastoma Multiforme.
Bernal Rubio YL; González-Reymúndez A; Wu KH; Griguer CE; Steibel JP; de Los Campos G; Doseff A; Gallo K; Vazquez AI
G3 (Bethesda); 2018 Nov; 8(11):3627-3636. PubMed ID: 30228192
[TBL] [Abstract][Full Text] [Related]
20. MGSEA - a multivariate Gene set enrichment analysis.
Tiong KL; Yeang CH
BMC Bioinformatics; 2019 Mar; 20(1):145. PubMed ID: 30885118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]